Navigation Links
New BioTrends Report Explores Anticipated Treatment Pattern Shifts Expected with the Proposed Bundled Payment Structure Planned for 2011
Date:7/28/2009

EXTON, Pa., July 28 /PRNewswire/ -- BioTrends Research Group, Inc. recently released its baseline report assessing awareness of the Centers for Medicare and Medicaid Services (CMS) proposed dialysis bundled payment plan among Medical Directors and Renal Administrators in dialysis units across the country. Approximately half of the respondents were affiliated with large dialysis chains (i.e. Fresenius, DaVita, DCI) with the other half operating in small-to-medium sized dialysis chains, independent units, and hospital based units.

The report, based on survey responses from 160 Medical Directors and 117 Renal Administrators and supplemented with qualitative interviews conducted with key stakeholders (dialysis organization executives, renal organizations, key opinion leaders on the subject of bundling), examines awareness of the proposed bundle components, anticipated changes in practice management, the degree of control in decision making Medical Directors and Renal Administrators expect to have, and their overall concerns with bundle implementation. Specific impact on the utilization of ESAs, IV iron, Vitamin D, phosphate binders, and Amgen's Sensipar is explored as it relates to how likely various scenarios are and whether or not they are in the best interest of dialysis patients.

Although exact details of the bundled payment system have yet to be finalized and made official, Medical Directors and Renal Administrators are clearly concerned about the impact of these changes on the fiscal health (and viability) of their units as well as the potential impact on patient outcomes. The most valuable sources of information on bundling were noted as the Renal Physician's Association for Medical Directors and the ESRD Networks for Renal Administrators.

The full report is available for purchase at www.bio-trends.com. A follow up wave of this report is planned in early 2010 after additional details on the bundle legislation have been released.

About BioTrends Research Group, Inc.

BioTrends Research Group, Inc. (www.bio-trends.com) provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.

All company, brand, or product names contained in this document may be trademarks of their respective holders.


'/>"/>
SOURCE BioTrends Research Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New Study by BioTrends Highlights Practice Management Shifts Among Canadian Nephrologists
2. BioTrends Prepares to Field ChartTrends(TM) Reports to Cover the Use of Biologic Agents in Psoriasis and Rheumatoid Arthritis
3. New Report by BioTrends Research Group to Highlight the Launch of SIMPONI(R) (golimumab)
4. Product Shifts are Occurring in the Renal Anemia and Bone and Mineral Metabolism Markets According to the Most Recent TreatmentTrends(R): US Nephrology Report from BioTrends Research Group
5. BioTrends Announces a New Syndicated Report Series, LaunchTrends(TM): Feraheme
6. Virginia Tech Report Has National Importance
7. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
8. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
9. Haemacure Reports Third Quarter 2007 Results
10. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
11. Biotech Finishes on a High in August, Burrill Report Says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along ... updates for the primary prevention of cardiovascular diseases during the 15th Annual ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... LOS ANGELES (PRWEB) , ... October 12, 2017 ... ... of Parsa Mohebi Hair Restoration, has recently contributed a medical article to the ... doctors, on cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
(Date:9/13/2017)... --  OrthoAtlanta has been named the official orthopedic and ... for the 2018 College Football Playoff (CFP) National Championship to ... in Atlanta, Georgia . OrthoAtlanta is proud ... participating in many activities leading up to, and including the ... ...
Breaking Medicine Technology: